Oof, well written, particularly trenchant about McNamara's offering "which continues to undergo multiple silence changes".
In an action at odds with this widespread support, however, the British Medical Association (BMA) Council, without consultation with its wider membership, passed a motion in July to ‘publicly critique’ the Review and called for its implementation to be paused pending this critique.5 This unexpected announcement was founded on ‘concern about weaknesses in methodologies’, referencing two papers: one, a preprint of a paper by Noone et al yet to undergo peer review,6 and another, a non-peer-reviewed online-only paper by McNamara et al, which continues to undergo multiple silent changes.7 Of the two online papers, the paper by McNamara et al, titled ‘An Evidence-Based Critique of ‘The Cass Review’’ and hosted on the Yale Law School’s web page named The Integrity Project,8 is the more extensive, as it incorporates the arguments by Noone et al while adding additional claims of its own. The apparent imprimatur of Yale University on one of the sources may perhaps have imbued it with a status not normally attributed to a web-based publication that had not been peer reviewed. It should be noted, though, that a disclaimer clarifying it had no official endorsement from Yale University was eventually added.
The BMA Council did not specify the basis of its concerns beyond these online sources, nor identify which of the Review’s 32 recommendations it objected to, nor how the impact of a potential pause in the implementation might be mitigated for patients. Following some negative reaction from its membership and the wider clinical community, the BMA subsequently announced that it has changed its position from ‘public critique’ to a ‘position of neutrality’ while it conducts its own review.9